Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-07-21

FDA Approved: TRANDOLAPRIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for Trandolapril (generic) under the ANDA program. This confirms regulatory clearance related to th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trandolapril (trandolapril)

Snippet

SUPPL AP for TRANDOLAPRIL (TRANDOLAPRIL)